HRP20010770B1 - Thiazolidinedione derivative and its use as antidiabetic - Google Patents

Thiazolidinedione derivative and its use as antidiabetic

Info

Publication number
HRP20010770B1
HRP20010770B1 HR20010770A HRP20010770A HRP20010770B1 HR P20010770 B1 HRP20010770 B1 HR P20010770B1 HR 20010770 A HR20010770 A HR 20010770A HR P20010770 A HRP20010770 A HR P20010770A HR P20010770 B1 HRP20010770 B1 HR P20010770B1
Authority
HR
Croatia
Prior art keywords
antidiabetic
thiazolidinedione derivative
thiazolidinedione
derivative
Prior art date
Application number
HR20010770A
Other languages
English (en)
Inventor
David James Blackler Paul
Gordon Giles Robert
John Sasse Michael
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of HRP20010770A2 publication Critical patent/HRP20010770A2/hr
Publication of HRP20010770B1 publication Critical patent/HRP20010770B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HR20010770A 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic HRP20010770B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical
PCT/GB2000/001521 WO2000063205A2 (en) 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (2)

Publication Number Publication Date
HRP20010770A2 HRP20010770A2 (en) 2002-10-31
HRP20010770B1 true HRP20010770B1 (en) 2005-06-30

Family

ID=10851901

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010770A HRP20010770B1 (en) 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Country Status (42)

Country Link
EP (2) EP1173436B1 (enExample)
JP (2) JP4283449B2 (enExample)
KR (1) KR100601244B1 (enExample)
CN (2) CN1327447A (enExample)
AP (1) AP1562A (enExample)
AR (2) AR023562A1 (enExample)
AT (1) ATE268770T1 (enExample)
AU (2) AU4130900A (enExample)
BG (1) BG65864B1 (enExample)
BR (1) BR0009897A (enExample)
CA (1) CA2382036A1 (enExample)
CO (1) CO5170422A1 (enExample)
CZ (1) CZ300653B6 (enExample)
DE (1) DE60011419T2 (enExample)
DK (1) DK1173436T3 (enExample)
DZ (1) DZ3162A1 (enExample)
EA (1) EA004232B1 (enExample)
EG (1) EG24063A (enExample)
ES (1) ES2218146T3 (enExample)
GB (1) GB9909041D0 (enExample)
HK (1) HK1045151B (enExample)
HR (1) HRP20010770B1 (enExample)
HU (1) HUP0200865A3 (enExample)
IL (1) IL146078A0 (enExample)
MA (1) MA26783A1 (enExample)
MX (1) MXPA01010696A (enExample)
MY (1) MY126034A (enExample)
NO (1) NO320609B1 (enExample)
NZ (1) NZ515166A (enExample)
OA (1) OA11866A (enExample)
PE (1) PE20010050A1 (enExample)
PL (1) PL351135A1 (enExample)
PT (1) PT1173436E (enExample)
RS (1) RS50136B (enExample)
SI (1) SI1173436T1 (enExample)
SK (1) SK284991B6 (enExample)
TR (1) TR200103040T2 (enExample)
TW (1) TWI277616B (enExample)
UA (1) UA71615C2 (enExample)
UY (1) UY26112A1 (enExample)
WO (1) WO2000063205A2 (enExample)
ZA (1) ZA200108720B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
SI1448559T1 (sl) * 2001-11-21 2007-06-30 Smithkline Beecham Plc 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil-tiazolidin-2,4-dion- benzensulfonat; postopek za njegovo pripravo; njegovi polimorfi i, ii, iii; in njegova uporaba kot farmacevtska uäśinkovina
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ296472B6 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
RS50136B (sr) 2009-03-25
MXPA01010696A (es) 2002-06-04
SK14902001A3 (sk) 2002-02-05
YU81501A (sh) 2004-07-15
SK284991B6 (sk) 2006-04-06
DE60011419D1 (de) 2004-07-15
HUP0200865A2 (en) 2002-08-28
IL146078A0 (en) 2002-07-25
MY126034A (en) 2006-09-29
EP1411055A1 (en) 2004-04-21
AU2755202A (en) 2002-05-16
ZA200108720B (en) 2002-11-28
AR023562A1 (es) 2002-09-04
MA26783A1 (fr) 2004-12-20
KR20010110791A (ko) 2001-12-13
PT1173436E (pt) 2004-10-29
ATE268770T1 (de) 2004-06-15
EP1173436A2 (en) 2002-01-23
PL351135A1 (en) 2003-03-24
NO20015104L (no) 2001-12-19
SI1173436T1 (en) 2004-12-31
WO2000063205A3 (en) 2001-01-25
HK1045151B (en) 2005-03-18
UA71615C2 (uk) 2004-12-15
TR200103040T2 (tr) 2002-04-22
HRP20010770A2 (en) 2002-10-31
AU4130900A (en) 2000-11-02
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
AU765911B2 (en) 2003-10-02
KR100601244B1 (ko) 2006-07-19
OA11866A (en) 2006-03-02
WO2000063205A2 (en) 2000-10-26
DK1173436T3 (da) 2004-09-27
EA004232B1 (ru) 2004-02-26
UY26112A1 (es) 2000-12-29
HK1045151A1 (en) 2002-11-15
NZ515166A (en) 2004-02-27
PE20010050A1 (es) 2001-03-10
GB9909041D0 (en) 1999-06-16
JP2009143954A (ja) 2009-07-02
JP4283449B2 (ja) 2009-06-24
EP1173436B1 (en) 2004-06-09
BG106112A (bg) 2002-05-31
CZ20013759A3 (cs) 2002-05-15
EA200101101A1 (ru) 2002-04-25
CN101134756A (zh) 2008-03-05
AR023566A1 (es) 2002-09-04
DE60011419T2 (de) 2005-06-16
NO20015104D0 (no) 2001-10-19
BR0009897A (pt) 2002-04-16
CA2382036A1 (en) 2000-10-26
TWI277616B (en) 2007-04-01
DZ3162A1 (fr) 2000-10-26
BG65864B1 (bg) 2010-03-31
AP1562A (en) 2006-02-01
ES2218146T3 (es) 2004-11-16
HUP0200865A3 (en) 2005-04-28
CO5170422A1 (es) 2002-06-27
AP2001002331A0 (en) 2000-04-19
JP2002542242A (ja) 2002-12-10
CN1327447A (zh) 2001-12-19
NO320609B1 (no) 2005-12-27

Similar Documents

Publication Publication Date Title
HRP20010773B1 (en) Thiazolidinedione derivative and its use as antidiabetic
PL355333A1 (en) N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
IL149897A0 (en) Thiazolyl amide derivatives
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
PL364986A1 (en) Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents
IL146115A0 (en) Thiazolidinedione derivative and its use as antidiabetic
PT1464641E (pt) Derivados de 4-fenil-1-piperazinilo, -piperidinilo e -tetrahidropiridilo como antagonistas da dopamina d4
PL354877A1 (en) Novel thiazolidinedione derivatives as antidiabetic agents
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
AP2001002331A0 (en) Thiazolidinedione derivative and its use as antidiabetic
PL351115A1 (en) Thiazolidinedione derivative and its use as antidiabetic
EG22491A (en) Rest-breaking composition and use thereof
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
GB9927927D0 (en) Compound composition and use
SI1173434T1 (en) Thiazolidinedione derivative and its use as antidiabetic
AU9203401A (en) A thiazolidinedione derivative and its use as antidiabetic
SI1325000T1 (sl) Derivat tiazolidindiona in njegova uporaba kot antidiabetik
SI1231211T1 (en) Thiazolidinedione derivatives as antidiabetic agents
GB9911606D0 (en) Composition and use
AU2002352390A1 (en) Rosiglitazone citrate and its use as antidiabetic
SI1233964T1 (en) New use and novel n-azabicyclo-amide derivatives
EG24062A (en) Novel composition and use
HK1055428A (en) N-substituted 2-cyanopyrrolidines and their use as antidiabetic agents
AU2001258854A1 (en) Novel thiazolidinedione derivatives and use thereof as drugs
SI1244650T1 (en) Arylamine derivatives and their use as anti-telomerase agent

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20100406

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20110420